ClinConnect ClinConnect Logo
Search / Trial NCT06123767

Innovative Application of Pressure Gradient Measurement in Internal Carotid Stenosis in Patients Undergoing CAS

Launched by 4TH MILITARY CLINICAL HOSPITAL WITH POLYCLINIC, POLAND · Nov 3, 2023

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Cas (Carotid Artery Stenting) Ffr (Fractional Flow Reserve) Ffr Ct (Fractional Flow Reserve Computed Tomography) Carotid Artery Stenosis Functional Assessment Of The Stenosis Decision Making Algorithm

ClinConnect Summary

This clinical trial is exploring a new way to measure blood flow in patients with carotid artery stenosis, which is a narrowing of the arteries in the neck that can lead to strokes. The main goal is to find out if measuring the pressure in these arteries can help doctors decide which patients would benefit most from a procedure called carotid artery stenting (CAS), where a small tube is placed to open up the artery. This is important because while some patients may have significant narrowing, not everyone will benefit from the procedure, and the trial aims to identify those who will.

To be eligible for this study, participants must be adults over 18 with a certain level of carotid artery narrowing—more than 50% for those experiencing symptoms and more than 60% for those without symptoms. All interested patients will need to give their consent to participate. During the trial, participants can expect assessments before and after the CAS procedure, including tests for blood flow to the brain, cognitive function, and other neurological symptoms. This research could help improve how doctors assess and treat patients at risk for stroke due to carotid artery issues.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Stenosis of the internal carotid artery in symptomatic patients: \> 50%, (confirmed by non-invasive imaging studies: USG, angio-CT), qualified for angioplasty with stent implantation
  • Stenosis of the internal carotid artery in asymptomatic patients: \>60%, (confirmed by non-invasive imaging studies: USG, angio-CT), qualified for angioplasty with stent implantation
  • Age of patients: \> 18 years of age
  • Provided informed consent to participate in the study.
  • Exclusion Criteria:
  • Inability to obtain informed consent to participate in the study.
  • Difficult anatomy of the aortic arch and the descending cephalic arteries (increased atherosclerotic lesions, acute angle of departure of the common carotid arteries, kinking of the internal carotid arteries).

About 4th Military Clinical Hospital With Polyclinic, Poland

The 4th Military Clinical Hospital with Polyclinic in Poland is a leading healthcare institution dedicated to providing advanced medical care and conducting innovative clinical research. As a prominent sponsor of clinical trials, the hospital integrates military and civilian health services, ensuring the highest standards of patient safety and care. With a multidisciplinary team of experienced medical professionals, the facility focuses on various therapeutic areas, contributing to the advancement of medical knowledge and the development of new treatment options. The hospital's commitment to excellence and collaboration with various stakeholders positions it as a key player in the clinical research landscape in Poland.

Locations

Wrocław, , Poland

Wrocław, Dolnośląskie, Poland

Patients applied

0 patients applied

Trial Officials

Krzysztof Ściborski, MD, PhD

Principal Investigator

4th Military Hospital in Wrocław

Waldemar Banasiak, MD, PhD

Study Director

4th Military Hospital in Wrocław

Artur Telichowski, MD, PhD

Study Director

4th Military Clinical Hospital with Polyclinic, Poland

Adrian Doroszko, MD, PhD

Study Director

4th Military Clinical Hospital with Polyclinic, Poland

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported